A US federal judge has blocked the Pentagon from listing WuXi as a Chinese military-linked firm, halting a designation that the biotechnology company argued was arbitrary and politically motivated.
The ruling provides immediate relief to WuXi, which had challenged the listing in court, asserting that the classification lacked factual support and resulted from political pressure rather than objective assessment.
The decision removes a significant regulatory overhang for WuXi and potentially other Chinese biotech firms facing similar scrutiny.
Markets have closely watched the case as a bellwether for how US authorities will handle allegations of military ties in the commercial biotechnology sector.
The Pentagon's listing process has been a focal point of US-China trade tensions, with implications for supply chain security and investment flows.
This development comes amid broader escalation in US-China trade relations.